Read more
Focusing on all aspects of primary glomerulonephritis, from their epidemiologies and classification, to their pathogenesis and treatment, this third edition of Treatment of Primary Glomerulonephritis has been fully updated to include the latest research and evidence-based practice.
List of contents
- 1: Claudio Ponticelli and Richard Glassock: A definition, modern classification, and global epidemiology of primary glomerulonephritis
- 2: Richard Glassock: Symptomatic therapy
- 3: Claudio Ponticelli and Richard Glassock: The pharmacology of old and new agents for specific therapy of primary glomerular diseases
- 4: Claudio Ponticelli, Richard Glassock, and Rosanna Coppo: Minimal change disease
- 5: Claudio Ponticelli, Richard Glassock, and Francesco Scolari: Focal and segmental glomerular sclerosis
- 6: Claudio Ponticelli, Richard Glassock, and Patrizia Passerini: Membranous nephropathy
- 7: Richard Glassock, Claudio Ponticelli, and Kar Neng Lai: Immunoglobulin A nephropathy
- 8: Richard Glassock, Lee Hebert, Gabriella Moroni, and Claudio Ponticelli: Infection-related and renal-limited glomerulonephritis
- 9: Richard Glassock and Fernando C. Fervenza: C3 Glomerulopathies and 'idiopathic' immune complex membranoproliferative glomerulonephritis
- 10: Richard Glassock and Patrick Nachman: Renal-limited vasculitis
- 11: Claudio Ponticelli and Gabriella Moroni: Other primary glomerular diseases
About the author
Claudio Ponticelli is an acknowledged expert in the field of nephrology, particularly in glomerular diseases and kidney transplantation. In glomerular diseases, he devised an original therapeutic schedule in primary membranous nephropathy, and has also co-ordinated randomised clinical trials in minimal change disease, focal glomerular sclerosis, and IgA nephropathy. During his career, Professor Ponticelli has been a member of the Council of the Italian Society of Nephrology, the Italian-American Society of Nephrology, and served as the President of the Italian Society of Nephrology. He has received numerous awards, including the ERA/EDTA Award for outstanding scientific achievements.
Richard J. Glassock is an internationally recognised expert in the field of glomerular diseases and clinical nephrology. Currently Professor Emeritus at the David Geffen School of Medicine at UCLA, he is the past-president of the American Society of Nephrology, the National Kidney Foundation (USA), and past-Chairman of the American Board of Internal Medicine. Over his career he has been a visiting professor at over 100 academic institutions, and founded the NephSAP Journal of the American Society of Nephrology as Editor-in-Chief. He has received numerous awards and distinguished lectureships, including the David Hume Memorial Award of the National Kidney Foundation.
Summary
Focusing on all aspects of primary glomerulonephritis, from their epidemiologies and classification, to their pathogenesis and treatment, this third edition of Treatment of Primary Glomerulonephritis has been fully updated to include the latest research and evidence-based practice.
Additional text
Review from previous edition ...an excellent addition to the currently available publications on medical management of glomerular diseases...it offers in-depth discussions, critiques, and referenced coverage of key trials that influence decision making...comprehensive in its coverage and easy to read.
